Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.
Cooper LV, Erbeto TB, Danzomo AA, Abdullahi HW, Boateng K, Adamu US, Shuaib F, Modjirom N, Gray EJ, Bandyopadhyay AS, Zipursky S, Okiror SO, Grassly NC, Blake IM. Cooper LV, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2024 Apr;24(4):427-436. doi: 10.1016/S1473-3099(23)00688-6. Epub 2024 Jan 18. Lancet Infect Dis. 2024. PMID: 38246190 Free article.
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA; Chilean IPV/bOPV study group. O'Ryan M, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.
Sáez-Llorens X, Clemens R, Leroux-Roels G, Jimeno J, Clemens SA, Weldon WC, Oberste MS, Molina N, Bandyopadhyay AS. Sáez-Llorens X, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2016 Mar;16(3):321-30. doi: 10.1016/S1473-3099(15)00488-0. Epub 2015 Dec 21. Lancet Infect Dis. 2016. PMID: 26719058 Free PMC article. Clinical Trial.
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
Wright PF, Connor RI, Wieland-Alter WF, Hoen AG, Boesch AW, Ackerman ME, Oberste MS, Gast C, Brickley EB, Asturias EJ, Rüttimann R, Bandyopadhyay AS. Wright PF, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2016 Dec;16(12):1377-1384. doi: 10.1016/S1473-3099(16)30169-4. Epub 2016 Sep 13. Lancet Infect Dis. 2016. PMID: 27638357 Free PMC article. Clinical Trial.
The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.
John J, Giri S, Karthikeyan AS, Lata D, Jeyapaul S, Rajan AK, Kumar N, Dhanapal P, Venkatesan J, Mani M, Hanusha J, Raman U, Moses PD, Abraham A, Bahl S, Bandyopadhyay AS, Ahmad M, Grassly NC, Kang G. John J, et al. Among authors: bandyopadhyay as. J Infect Dis. 2017 Feb 15;215(4):529-536. doi: 10.1093/infdis/jiw595. J Infect Dis. 2017. PMID: 28003352 Free PMC article. Clinical Trial.
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.
Rivera L, Pedersen RS, Peña L, Olsen KJ, Andreasen LV, Kromann I, Nielsen PI, Sørensen C, Dietrich J, Bandyopadhyay AS, Thierry-Carstensen B. Rivera L, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2017 Jul;17(7):745-753. doi: 10.1016/S1473-3099(17)30177-9. Epub 2017 Apr 25. Lancet Infect Dis. 2017. PMID: 28454674 Free PMC article. Clinical Trial.
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.
Taniuchi M, Famulare M, Zaman K, Uddin MJ, Upfill-Brown AM, Ahmed T, Saha P, Haque R, Bandyopadhyay AS, Modlin JF, Platts-Mills JA, Houpt ER, Yunus M, Petri WA Jr. Taniuchi M, et al. Among authors: bandyopadhyay as. Lancet Infect Dis. 2017 Oct;17(10):1069-1079. doi: 10.1016/S1473-3099(17)30358-4. Epub 2017 Jul 7. Lancet Infect Dis. 2017. PMID: 28693854 Free PMC article. Clinical Trial.
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB, Strauch CB, Wieland-Alter WF, Connor RI, Lin S, Weiner JA, Ackerman ME, Arita M, Oberste MS, Weldon WC, Sáez-Llorens X, Bandyopadhyay AS, Wright PF. Brickley EB, et al. Among authors: bandyopadhyay as. J Infect Dis. 2018 Jan 17;217(3):371-380. doi: 10.1093/infdis/jix556. J Infect Dis. 2018. PMID: 29304199 Free PMC article. Clinical Trial.
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
Blake IM, Pons-Salort M, Molodecky NA, Diop OM, Chenoweth P, Bandyopadhyay AS, Zaffran M, Sutter RW, Grassly NC. Blake IM, et al. Among authors: bandyopadhyay as. N Engl J Med. 2018 Aug 30;379(9):834-845. doi: 10.1056/NEJMoa1716677. N Engl J Med. 2018. PMID: 30157398 Free PMC article.
80 results